Cargando…
iTEARS: a novel platform for using tears as potential disease biomarkers
Autores principales: | Khan, Abdul Moiz, Shahnoor, Syeda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389382/ https://www.ncbi.nlm.nih.gov/pubmed/36799793 http://dx.doi.org/10.1097/JS9.0000000000000087 |
Ejemplares similares
-
Metallic nanoparticle-coated sutures: a breakthrough in the field of surgery
por: Khan, Abdul Moiz, et al.
Publicado: (2023) -
“Veozah (Fezolinetant): A Promising Non‐Hormonal Treatment for Vasomotor Symptoms in Menopause”
por: Shaukat, Ayesha, et al.
Publicado: (2023) -
Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence
por: Khan, Abdul Moiz, et al.
Publicado: (2023) -
Artificial tears: Promising treatment or silent threat to public health?
por: Mughal, Sanila, et al.
Publicado: (2023) -
Advancing precision oncology in breast cancer: the FDA approval of elacestrant and Guardant360 CDx: a correspondence
por: Abbasi, Haleema Qayyum, et al.
Publicado: (2023)